Skip to main content
. Author manuscript; available in PMC: 2008 Aug 31.
Published in final edited form as: J Immunol Methods. 2007 Jun 28;325(1-2):51–66. doi: 10.1016/j.jim.2007.05.013

Figure 7.

Figure 7

Comparisons of the 3h FCC assay with 4 h CRA. PBMC were co-incubated with K562 targets. Non-transformed data obtained with PBMC of normal donors (n = 11) and patients with cancer (n = 15). PBMC of 12 normal donors were also stimulated with IL-2 and tested for LAK activity with Daudi targets.